INVESTIGATION OF MODIFIED SORAFENIB DERIVATIVES AS A TYROSINE KINASE INHIBITORS OF LEUKIMIA VIA MOLECULAR DOCKING. FMHR [Internet]. 2026 May 20 [cited 2026 May 21];4(5):567-85. Available from: https://fmhr.net/index.php/fmhr/article/view/2904